Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE.

Adamo, Marianna; Russo, Giulio; Pagnesi, Matteo; Pancaldi, Edoardo; Alessandrini, Hannes; Andreas, Martin; Badano, Luigi P; Braun, Daniel; Connelly, Kim A; Denti, Paolo; Estevez-Loureiro, Rodrigo; Fam, Neil; Gavazzoni, Mara; Hahn, Rebecca T; Harr, Claudia; Hausleiter, Joerg; Himbert, Dominique; Kalbacher, Daniel; Ho, Edwin; Latib, Azeem; ... (2024). Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE. JACC. Cardiovascular Interventions, 17(7), pp. 859-870. Elsevier 10.1016/j.jcin.2024.02.013

[img] Text
1-s2.0-S1936879824004588-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (742kB) | Request a copy


Data on the prognostic role of the TRI-SCORE in patients undergoing transcatheter tricuspid valve intervention (TTVI) are limited.


The aim of this study was to evaluate the performance of the TRI-SCORE in predicting outcomes of patients undergoing TTVI.


TriValve (Transcatheter Tricuspid Valve Therapies) is a large multicenter multinational registry including patients undergoing TTVI. The TRI-SCORE is a risk model recently proposed to predict in-hospital mortality after tricuspid valve surgery. The TriValve population was stratified based on the TRI-SCORE tertiles. The outcomes of interest were all-cause death and all-cause death or heart failure hospitalization. Procedural complications and changes in NYHA functional class were also reported.


Among the 634 patients included, 223 patients (35.2%) had a TRI-SCORE between 0 and 5, 221 (34.8%) had 6 or 7, and 190 (30%) had ≥8 points. Postprocedural blood transfusion, acute kidney injury, new atrial fibrillation, and in-hospital mortality were more frequent in the highest TRI-SCORE tertile. Postprocedure length of stay increased with a TRI-SCORE increase. A TRI-SCORE ≥8 was associated with an increased risk of 30-day all-cause mortality and all-cause mortality and the composite endpoint assessed at a median follow-up of 186 days (OR: 3.00; 95% CI: 1.38-6.55; HR: 2.17; 95% CI: 1.78-4.13; HR: 2.08, 95% CI: 1.57-2.74, respectively) even after adjustment for procedural success and EuroSCORE II or Society of Thoracic Surgeons Predicted Risk of Mortality. The NYHA functional class improved across all TRI-SCORE values.


In the TriValve registry, the TRI-SCORE has a suboptimal performance in predicting clinical outcomes. However, a TRISCORE ≥8 is associated with an increased risk of clinical events and a lack of prognostic benefit after successful TTVI.

Item Type:

Journal Article (Original Article)


04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Praz, Fabien Daniel, Windecker, Stephan


600 Technology > 610 Medicine & health








Pubmed Import

Date Deposited:

11 Apr 2024 14:24

Last Modified:

11 Apr 2024 22:45

Publisher DOI:


PubMed ID:


Uncontrolled Keywords:

risk model transcatheter tricuspid valve intervention tricuspid regurgitation




Actions (login required)

Edit item Edit item
Provide Feedback